Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Grunberger Diabetes Institute (GDI) is a specialized medical facility and clinical research center based in Bloomfield Hills, Michigan. Founded by Dr. George Grunberger, the institute provides comprehensive clinical care for patients with diabetes and other endocrine disorders while operating a robust clinical trials division. GDI serves as a high-quality site for Phase 1 through Phase 4 clinical trials, partnering with global pharmaceutical companies to evaluate new medications, delivery systems, and glucose monitoring technologies. The institute is highly regarded for its integration of patient education, advanced clinical practice, and cutting-edge metabolic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grunberger Diabetes Institute.